Singapore publishes Summary Reports of Benefit-Risk Assessment for NCE/NBE online

Effective from June 2020 onward the Health Sciences Authority, Singapore will be publishing the Summary Reports of Benefit-Risk Assessments for …

read more...

Singapore launches new E-FORM for Therapeutic Products(TP)

Health Sciences Authority (HSA) Singapore launches a new online form to enable submission of post-approval documents/data of therapeutic products (TP) …

read more...

Singapore launches new e-form for post-approval Registration Conditions of Therapeutic Products

Health Sciences Authority (HSA) Singapore launches a new online form to enable submission of post-approval documents/data of therapeutic products (TP) …

read more...

Field Safety Corrective Action (FSCA) launched by HSA Singapore

Effective from 6 April 2020, the Health Science Authority(HSA ) of Singapore has launched the new OSCAR system for Field …

read more...

Singapore adds controls to certain mercury-added medical devices under EPMA

Singapore adds certain medical devices to the control list of Mercury-Added Products under the Environmental Protection and Management Act (“EPMA”). …

read more...

Singapore HSA released registration requirements on Next Generation Sequencing IVDs

Singapore, Health Sciences Authority (HSA) released the final document on Next Generation Sequencing NGS IVDs. This document focuses on the …

read more...